Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type 2 diabetes in Canada
Aim: Clinical trials and real-world data for Type 2 diabetes have shown that real-time continuous glucose monitoring (rt-CGM) lowers glycated hemoglobin (A1c) and reduces hypoglycemia relative to self-monitoring of blood glucose (SMBG). This analysis examined the long-term health and economic out...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Becaris Publishing Limited
2023-09-01
|
Series: | Journal of Comparative Effectiveness Research |
Subjects: |